Ticker

BEAM

Beam Therapeutics Inc.

11 catalysts on file

BEAM

Beam Therapeutics Inc.

Phase 2 AI-extracted

BEAM-302

alpha-1 antitrypsin deficiency

143d ago ~ Mar 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

Phase 3 AI-extracted

risto-cel

sickle cell disease

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

AdCom AI-extracted

BEAM-302

alpha-1 antitrypsin deficiency

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

Phase 1 AI-extracted

BEAM-304

phenylketonuria

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

Phase 2 AI-extracted

BEAM-304

phenylketonuria

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

Approval AI-extracted

risto-cel

sickle cell disease

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

PDUFA AI-extracted

BEAM-302

alpha-1 antitrypsin deficiency (AATD)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

Phase 1 AI-extracted

BEAM-302

alpha-1 antitrypsin deficiency (AATD)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

Phase 1 AI-extracted

BEAM-301

glycogen storage disease type Ia (GSDIa)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

PDUFA AI-extracted

risto-cel

sickle cell disease (SCD)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BEAM

Beam Therapeutics Inc.

CRL AI-extracted

BEAM-304

phenylketonuria (PKU)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →